Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.
作者信息
Kirklin James K, Naftel David C, Kormos Robert L, Stevenson Lynne W, Pagani Francis D, Miller Marissa A, Ulisney Karen L, Baldwin J Timothy, Young James B
机构信息
University of Alabama at Birmingham, Alabama 35294, USA.
出版信息
J Heart Lung Transplant. 2010 Jan;29(1):1-10. doi: 10.1016/j.healun.2009.10.009.
Abstract
摘要
相似文献
1
Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.
J Heart Lung Transplant. 2010 Jan;29(1):1-10. doi: 10.1016/j.healun.2009.10.009.
2
Concomitant aortic valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: An INTERMACS database analysis.
J Heart Lung Transplant. 2015 Jun;34(6):797-805. doi: 10.1016/j.healun.2014.11.008. Epub 2014 Nov 15.
3
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
J Am Coll Cardiol. 2011 May 10;57(19):1890-8. doi: 10.1016/j.jacc.2010.10.062.
4
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
J Heart Lung Transplant. 2014 Jan;33(1):12-22. doi: 10.1016/j.healun.2013.11.001. Epub 2013 Nov 27.
5
Pulmonary Arterial Elastance and INTERMACS-Defined Right Heart Failure Following Left Ventricular Assist Device.
Circ Heart Fail. 2019 Aug;12(8):e005923. doi: 10.1161/CIRCHEARTFAILURE.119.005923. Epub 2019 Aug 12.
6
Quality of Life After Left Ventricular Assist Device Implantation: In a World Full of Data, #Missingness.
J Card Fail. 2016 May;22(5):338-9. doi: 10.1016/j.cardfail.2016.01.014. Epub 2016 Feb 2.
7
Ventricular Assist Device in Acute Myocardial Infarction.
J Am Coll Cardiol. 2016 Apr 26;67(16):1871-80. doi: 10.1016/j.jacc.2016.02.025.
8
Left ventricular assist device implantation: short and long-term surgical complications.
J Heart Lung Transplant. 2000 Aug;19(8 Suppl):S89-94. doi: 10.1016/s1053-2498(99)00110-2.
9
Preoperative risk factors for mortality after biventricular assist device implantation.
J Card Fail. 2008 Dec;14(10):844-9. doi: 10.1016/j.cardfail.2008.08.009. Epub 2008 Oct 14.
10
Right ventricular assist device with membrane oxygenator support for right ventricular failure following implantable left ventricular assist device placement.
Eur J Cardiothorac Surg. 2016 Jan;49(1):73-7. doi: 10.1093/ejcts/ezv116. Epub 2015 Apr 15.
引用本文的文献
1
Immune response against antibiotic-resistant and antibiotic-sensitive staphylococcus aureus in a rat model of implant infection.
Sci Rep. 2025 Apr 17;15(1):13264. doi: 10.1038/s41598-025-95004-y.
2
What happens when a disruptive technology gets disrupted?
Am Heart J Plus. 2021 Jul 5;6:100031. doi: 10.1016/j.ahjo.2021.100031. eCollection 2021 Jun.
3
Cellular and Molecular Mechanisms Activated by a Left Ventricular Assist Device.
Int J Mol Sci. 2023 Dec 24;25(1):288. doi: 10.3390/ijms25010288.
4
Using Graphene-Based Materials for Stiff and Strong Poly(ethylene glycol) Hydrogels.
Int J Mol Sci. 2022 Feb 19;23(4):2312. doi: 10.3390/ijms23042312.
5
Adverse events in patients with a left ventricular assist device: are patient-reported outcomes affected?
Eur J Cardiovasc Nurs. 2022 Apr 9;21(3):254-260. doi: 10.1093/eurjcn/zvab070.
6
Contemporary outcomes of continuous-flow biventricular assist devices.
Ann Cardiothorac Surg. 2021 May;10(3):311-328. doi: 10.21037/acs-2021-cfmcs-34.
7
Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge.
J Arrhythm. 2021 May 5;37(3):535-543. doi: 10.1002/joa3.12542. eCollection 2021 Jun.
8
An unusual case of fungaemia in an immunocompetent patient with a left ventricular assist device and an implantable cardiac device.
Access Microbiol. 2020 Jun 25;2(9):acmi000148. doi: 10.1099/acmi.0.000148. eCollection 2020.
9
Forensic Considerations in a Series of 14 Deaths of Patients with a Left Ventricular Assist Device.
Acad Forensic Pathol. 2019 Sep;9(3-4):200-211. doi: 10.1177/1925362119893459. Epub 2020 Jan 31.
10
Understanding and Addressing Variation in Health Care-Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study.
JMIR Res Protoc. 2020 Jan 7;9(1):e14701. doi: 10.2196/14701.
本文引用的文献
1
INTERMACS profiles of advanced heart failure: the current picture.
J Heart Lung Transplant. 2009 Jun;28(6):535-41. doi: 10.1016/j.healun.2009.02.015.
2
INTERMACS database for durable devices for circulatory support: first annual report.
J Heart Lung Transplant. 2008 Oct;27(10):1065-72. doi: 10.1016/j.healun.2008.07.021.
3
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure.
Ann Thorac Surg. 1999 Mar;67(3):723-30. doi: 10.1016/s0003-4975(99)00042-9.
Zotero 插件